BioCentury
ARTICLE | Company News

NeoStem management update

July 29, 2013 7:00 AM UTC

NeoStem Inc. (NYSE-M:NBS), New York, N.Y. Business: Gene/Cell therapy, Supply/Service Transitioned: Stephen Potter to EVP from a director, formerly SVP of operations and corporate development at Osir...